RENX ENTERPRISES CORP

Renalytix’s kidneyintelX.dkd test aligns with the new U.S. Kidney Care National Plan, Medicare‑reimbursed and ready for Quest Diagnostics rollout, boosting early kidney disease detection and potential cost savings.

RenX Enterprises reports Q3 2026 growth in organics deliveries and a new Microtec milling system, boosting sustainable material production and market value.